¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

´ëÇÑÇ÷°ü¿Ü°úÇÐȸ 2022 KSVS Vascular and Endovascular Surgery Conference : 2022-09-24

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
´ëÇÑÇ÷°ü¿Ü°úÇÐȸ 2022 KSVS Vascular and Endovascular Surgery Conference : 2022-09-24
±³À°ÀÏÀÚ : 2022-09-24
±³À°Àå¼Ò : The-K È£ÅÚ ¼­¿ï 3Ãþ °Å¹®°íȦ  
±³À°ÁÖÁ¦ : 2022 KSVS Vascular and Endovascular Surgery Conference
ÁÖÃÖ±â°ü : ´ëÇÑÇ÷°ü¿Ü°úÇÐȸ
´ã´çÀÚ : ´ëÇÑÇ÷°ü¿Ü°úÇÐȸ
¿¬¶ôó : 02-1111-1111  
À̸ÞÀÏ : ksvs@chol.com      
±³À°Á¾·ù : ¿Ü°ú, ÈäºÎ¿Ü°ú      
Âü¼®¿¹»óÀοø : 250¸í
Èñ¸ÁÆòÁ¡ : 6Á¡  
Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 6 ½Ã°£ 40ºÐ  
¼¼ºÎ¼ö°­·á : 180,000¿ø      
ºñ°í ¡Ø»çÀüµî·Ï: Á¤È¸¿ø Àü¹®ÀÇ, ÁØȸ¿ø: 100,000¿ø / ºñȸ¿ø Àü¹®ÀÇ 150,000¿ø / ÀϹÝÀÇ, Àü°øÀÇ, °£È£»ç, ±â»ç, ±âŸ 50,000¿ø ¡ØÇöÀåµî·Ï: Á¤È¸¿ø Àü¹®ÀÇ, ÁØȸ¿ø: 130,000¿ø / ºñȸ¿ø Àü¹®ÀÇ 180,000¿ø / ÀϹÝÀÇ, Àü°øÀÇ, °£È£»ç, ±â»ç, ±âŸ 80,000¿ø      

±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±âŸ 09-24 The-K È£ÅÚ ¼­¿ï 3Ãþ °Å¹®°íȦ 08:30~08:55 Registration  () 
±âŸ 09-24 The-K È£ÅÚ ¼­¿ï 3Ãþ °Å¹®°íȦ 08:55~09:00 Welcome message  ±èµ¿ÀÍ(´ëÇÑÇ÷°ü¿Ü°úÇÐȸ ȸÀå) 
±³À°½Ã°£ 09-24 The-K È£ÅÚ ¼­¿ï 3Ãþ °Å¹®°íȦ 09:00~09:10 Non-invasive vascular laboratory  Çã¼±Èñ(¿¬¼¼ÀÇ´ë) 
±³À°½Ã°£ 09-24 The-K È£ÅÚ ¼­¿ï 3Ãþ °Å¹®°íȦ 09:10~09:20 Medical treatment of PAD  ÇѾƶ÷(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 09-24 The-K È£ÅÚ ¼­¿ï 3Ãþ °Å¹®°íȦ 09:20~09:30 Cause and management of acute arterial thrombosis: endo vs. surgery vs. hybrid  À±¿ì¼º(°æºÏÀÇ´ë) 
±³À°½Ã°£ 09-24 The-K È£ÅÚ ¼­¿ï 3Ãþ °Å¹®°íȦ 09:30~09:40 Role of bypass surgery in the endovascular era  ÀÌÈ£±Õ(Àü³²ÀÇ´ë) 
±³À°½Ã°£ 09-24 The-K È£ÅÚ ¼­¿ï 3Ãþ °Å¹®°íȦ 09:40~09:50 Algorithm on SFA disease management: ballooning, stenting, atherectomy and drug elution  ¹ÚÀÇÁØ(°è¸íÀÇ´ë) 
±³À°½Ã°£ 09-24 The-K È£ÅÚ ¼­¿ï 3Ãþ °Å¹®°íȦ 09:50~10:00 Re-entry techniques in CTO lesions: Tips and tricks  È²È«ÇÊ(ÀüºÏÀÇ´ë) 
Åä·Ð 09-24 The-K È£ÅÚ ¼­¿ï 3Ãþ °Å¹®°íȦ 10:00~10:20 Discussion  Á¶¿ëÇÊ ÀÌ»ó¼ö(¿ï»êÀÇ´ë ºÎ»êÀÇ´ë) 
È޽Ġ09-24 The-K È£ÅÚ ¼­¿ï 3Ãþ °Å¹®°íȦ 10:20~10:40 Coffee break  () 
±³À°½Ã°£ 09-24 The-K È£ÅÚ ¼­¿ï 3Ãþ °Å¹®°íȦ 10:40~10:50 Open surgical repair: transperitoneal vs. retroperitoneal approach  °­Áø¸ð(°¡ÃµÀÇ´ë) 
±³À°½Ã°£ 09-24 The-K È£ÅÚ ¼­¿ï 3Ãþ °Å¹®°íȦ 10:50~11:00 Standard EVAR techniques and bail-out procedures  ÀÌÀçÈÆ(´ë±¸°¡Å縯ÀÇ´ë) 
±³À°½Ã°£ 09-24 The-K È£ÅÚ ¼­¿ï 3Ãþ °Å¹®°íȦ 11:00~11:10 EVAR for hostile neck anatomy  ±èÀå¿ë(°¡Å縯ÀÇ´ë) 
±³À°½Ã°£ 09-24 The-K È£ÅÚ ¼­¿ï 3Ãþ °Å¹®°íȦ 11:10~11:20 EVAR for complex Iliac anatomy  ±è»óµ¿(°¡Å縯ÀÇ´ë) 
±³À°½Ã°£ 09-24 The-K È£ÅÚ ¼­¿ï 3Ãþ °Å¹®°íȦ 11:20~11:30 Treatment of mycotic aneurysm: Can EVAR be the initial treatment?  ¹Ú¾çÁø(¼º±Õ°üÀÇ´ë) 
±³À°½Ã°£ 09-24 The-K È£ÅÚ ¼­¿ï 3Ãþ °Å¹®°íȦ 11:30~11:40 Debranching procedures for Zone 1 or 2 TEVAR  Á¤ÇõÀç(ºÎ»êÀÇ´ë) 
Åä·Ð 09-24 The-K È£ÅÚ ¼­¿ï 3Ãþ °Å¹®°íȦ 11:40~12:00 Discussion  () 
±³À°½Ã°£ 09-24 The-K È£ÅÚ ¼­¿ï 3Ãþ °Å¹®°íȦ 12:00~12:30 Luncheon session  Çã½Â(°æºÏÀÇ´ë) 
½Ä»ç 09-24 The-K È£ÅÚ ¼­¿ï 3Ãþ °Å¹®°íȦ 12:30~13:00 Lunch  () 
±³À°½Ã°£ 09-24 The-K È£ÅÚ ¼­¿ï 3Ãþ °Å¹®°íȦ 13:00~14:00 My Best or Worst Case  ÃÖ¼öÁø³ª ±èÇü±â(Àü³²ÀÇ´ë °æºÏÀÇ´ë) 
±³À°½Ã°£ 09-24 The-K È£ÅÚ ¼­¿ï 3Ãþ °Å¹®°íȦ 14:00~14:10 Vascular access: The nephrology perspective  ÀÌÇü¼®(ÇѸ²ÀÇ´ë) 
±³À°½Ã°£ 09-24 The-K È£ÅÚ ¼­¿ï 3Ãþ °Å¹®°íȦ 14:10~14:20 Selection of AV access type and location for hemodialysis  À±»óö(¼øõÇâÀÇ´ë) 
±³À°½Ã°£ 09-24 The-K È£ÅÚ ¼­¿ï 3Ãþ °Å¹®°íȦ 14:20~14:30 Thrombosed AV access: Are percutaneous treatment options superior to open thrombectomy?  º¯½ÂÀç(À¯Ã¢Çöº¯½ÂÀç¿Ü°ú) 
±³À°½Ã°£ 09-24 The-K È£ÅÚ ¼­¿ï 3Ãþ °Å¹®°íȦ 14:30~14:40 AV access in patients with central venous occlusion  ÀüÈ︸(°í·ÁÀÇ´ë) 
±³À°½Ã°£ 09-24 The-K È£ÅÚ ¼­¿ï 3Ãþ °Å¹®°íȦ 14:40~14:50 Steal syndrome: Diagnosis and treatment options  ³ë¿µ³²(¿µ³²ÀÇ´ë) 
Åä·Ð 09-24 The-K È£ÅÚ ¼­¿ï 3Ãþ °Å¹®°íȦ 14:50~15:10 Discussion  À±»ó¼· ±èÇüÅÂ(°¡Å縯ÀÇ´ë ºêÀÌ¿Ü°ú) 
È޽Ġ09-24 The-K È£ÅÚ ¼­¿ï 3Ãþ °Å¹®°íȦ 15:10~15:30 Coffee break  () 
±³À°½Ã°£ 09-24 The-K È£ÅÚ ¼­¿ï 3Ãþ °Å¹®°íȦ 15:30~15:40 Duration of anticoagulation therapy for acute VTE  È²Á¤±â(°¡Å縯ÀÇ´ë) 
±³À°½Ã°£ 09-24 The-K È£ÅÚ ¼­¿ï 3Ãþ °Å¹®°íȦ 15:40~15:50 Acute DVT intervention: Who, when and how?  ¾È»óÇö(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 09-24 The-K È£ÅÚ ¼­¿ï 3Ãþ °Å¹®°íȦ 15:50~16:00 Will non-thermal ablation will soon eliminate thermal technique?  ¹ÚÀμö(ÂüÇÏÁö¿Ü°ú) 
±³À°½Ã°£ 09-24 The-K È£ÅÚ ¼­¿ï 3Ãþ °Å¹®°íȦ 16:00~16:10 Recurrent varicose veins after endovenous ablation: Causes and treatment options  Àü°­¿õ(°¡Å縯ÀÇ´ë) 
±³À°½Ã°£ 09-24 The-K È£ÅÚ ¼­¿ï 3Ãþ °Å¹®°íȦ 16:10~16:20 Timing of intervention for symptomatic carotid artery stenosis  ¾ç½Å¼®(¼º±Õ°üÀÇ´ë) 
±³À°½Ã°£ 09-24 The-K È£ÅÚ ¼­¿ï 3Ãþ °Å¹®°íȦ 16:20~16:30 The asymptomatic carotid stenosis: intervene or not?  ±ÇÁر³(¿ï»êÀÇ´ë) 
Åä·Ð 09-24 The-K È£ÅÚ ¼­¿ï 3Ãþ °Å¹®°íȦ 16:30~16:50 Discussion  ¾È¹®»ó ¹Ú»óÁØ(Ãæ³²ÀÇ´ë ¿ï»êÀÇ´ë) 
±âŸ 09-24 The-K È£ÅÚ ¼­¿ï 3Ãþ °Å¹®°íȦ 16:50~17:00 Awards ceremony and Closing message  Çã½Â(´ëÇÑÇ÷°ü¿Ü°úÇÐȸ ÀÌ»çÀå) 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" ´ëÇÑÇ÷°ü¿Ü°úÇÐȸ 2022 KSVS Vascular and Endovascular Surgery Conference : 2022-09-24""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û ¼­¿ï¾Æ»êº´¿ø À̺ñÀÎÈÄ°ú Áý´ãȸ(µÎ°æºÎ ÃÊÀ½ÆÄ, û·Â °³¼± ¼ö¼ú) : 2022-09-24
´ÙÀ½±Û 2022³â ÇѸ²´ëÇб³¼º½Éº´¿ø ¿Ü°ú °³¿øÀÇ ¿¬¼ö°­Á : 2022-09-24
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20895 ¼­¿ï ´ëÇѼҾƽÅÀåÇÐȸ (¿Â¶óÀÎ) 2024³â ¼Ò¾Æ½ÅÀå Post-graduate education course : 2024-07-01 0 6 2024-05-28
20894 ´ëÀü Ãæ³²´ëÇб³º´¿ø 2024³â °³¿øÀÇ¿Í ÇÔ²²ÇÏ´Â ³»°ú ¿¬¼ö°­Á : 2024-06-30 0 8 2024-05-28
20893 ¼­¿ï ´ëÇѳúÁ¹ÁßÇÐȸ 6¿ù º¸¼ö±³À° : 2024-06-30 0 113 2024-05-27
20892 ¼­¿ï (¿Â¶óÀÎ)Á¦22Â÷ ¼­¿ïƯº°½ÃÀÇ»çȸ Çмú´ëȸ : 2024-06-30 0 21 2024-05-27
20891 °æ±â (¿Â¶óÀÎ)Á¦21Â÷ °æ±âµµÀÇ»çȸ ¿Â¶óÀÎ Çмú´ëȸ : 2024-06-30 0 78 2024-05-27
20890 Àü³² 2024³â ´ëÇÑ´ëÀåÇ×¹®ÇÐȸ ¿¬¼ö°­Á : 2024-06-30 0 13 2024-05-27
20889 Ãæ³² ´ëÇÑÁ¤Çü¿Ü°úÃÊÀ½ÆÄÇÐȸ - Á¦19Â÷ Ãá°èÇмú´ëȸ ¹× Á¦38Â÷ ±Ù°ñ°Ý°è ÃÊÀ½ÆÄ¿öÅ©¼¥ (Basic Course) : 2024-06-30 0 10 2024-05-27
20888 ºÎ»ê Á¦3ȸ ´ëÇÑÅõ¼®Çùȸ ºÎ»êÁöȸ ½ÉÆ÷Áö¾ö : 2024-06-29 0 8 2024-05-27
20887 ¼­¿ï Çѱ¹ÁöÁú¤ýµ¿¸Æ°æÈ­ÇÐȸ Á¦7ȸ A to Z (Atherosclerosis to Zero) ¿¬¼ö°­Á ÇÁ·Î±×·¥ : 2024-06-29 0 28 2024-05-27
20886 °æ±â 2024³âµµ ³²¾çÁÖ½ÃÀÇ»çȸ Çмú´ëȸ : 2024-06-29 0 5 2024-05-27
20885 ¼­¿ï (¿Â¶óÀÎ)Á¦14ȸ ´ëÇÑ°¨¿°ÇÐȸ Æò»ý±³À° ÇÁ·Î±×·¥ °¨¿°Áúȯ ÃÖ½ÅÁö°ß : 2024-06-29 0 10 2024-05-27
20884 ¼­¿ï Á¦24Â÷ ´ëÇѽÅÀåÇÐȸ ½ÅÀ̽Ŀ¬±¸È¸ ¿¬¼ö°­Á : 2024-06-29 0 2 2024-05-27
20883 ¼­¿ï 2024 ¼±Ãµ¼º Ⱦ°æ¸· Å»Àå ÄÚȣƮ (K-CDH) ±³À°¼¼¹Ì³ª : 2024-06-29 0 11 2024-05-27
20882 ¼­¿ï 2024 ¿©¼º½ÉÀåÁúȯ¿¬±¸È¸ ÇÏ°è ½ÉÆ÷Áö¾ö : 2024-06-29 0 9 2024-05-27
20881 °­¿ø 2024 ³âµµ Á¤Çü¿Ü°úÇб³½Ç °³¿øÀÇ¿¬¼ö°­Á : 2024-06-29 0 12 2024-05-27
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷